Related Experiment Video
Updated: Jul 7, 2026
16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
[Rasagiline in Parkinson's disease]
1Centro de Investigación Parkinson, Policlínica Guipuzkoa, San Sebastián, Spain. glinazasoro@terra.es
Neurologia (Barcelona, Spain)
|March 1, 2008
Summary
Rasagiline, a selective monoamine oxidase-B inhibitor, is safe and effective for Parkinson's disease (PD) management. Early use may improve patient outcomes and potentially offer neuroprotection.
Area of Science:
- Pharmacology
- Neuroscience
Context:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder.
- Current treatments aim to manage motor symptoms and improve quality of life.
Purpose:
- To evaluate the efficacy and safety of rasagiline in Parkinson's disease.
- To explore the potential benefits of early rasagiline intervention.
Summary:
- Rasagiline is a selective, irreversible monoamine oxidase-B inhibitor with no amphetamine metabolites.
- It demonstrates safety and efficacy as monotherapy in early PD and as adjuvant therapy with levodopa.
- Well-tolerated in aged patients, rasagiline offers convenient once-daily dosing and can be combined with other PD medications.
Impact:
- Early rasagiline use may enhance long-term outcomes for Parkinson's disease patients.
- Investigational studies suggest potential neuroprotective effects, warranting further research.
- Rasagiline is a well-suited option for initial Parkinson's disease treatment.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.